首页 › 基金 › Hosking Partners LLP › BIO
Hosking Partners LLP 对 BIO 的持仓历史
BIO RAD LABS INC · 工业
Hosking Partners LLP 在 Q3 2026 的 13F 申报中披露持有 BIO(BIO RAD LABS INC)95,472 股,市值约 US$36.1M,约占其申报组合的 1.28%,在其申报持仓中市值排名第 28 位。 Hosking Partners LLP 最近 13 个申报季度中有 13 个季度披露了 BIO 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Hosking Partners LLP 对 BIO 的持仓演变
Hosking Partners LLP 于 Q3 2023 首次披露 BIO 持仓:74,226 股(约 US$26.6M)。 该持仓在 Q3 2026 达到峰值 95,472 股,市值约 US$36.1M。 在 13 次申报中,Hosking Partners LLP 3 次增持、6 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 95,472 股、市值约 US$36.1M,环比增持 1,042 股。。 持仓曾出现大幅变动:Q1 2026 增持约 28% (随后一个季度股价上涨 5%)、Q2 2026 增持约 37% (随后一个季度股价上涨 29%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 74.23K | $26.61M | 新进 |
| Q4 2023 | 69.22K | $22.35M | 减持 |
| Q1 2024 | 69.01K | $23.87M | 持有 |
| Q2 2024 | 65.07K | $17.77M | 减持 |
| Q3 2024 | 62.11K | $20.78M | 减持 |
| Q4 2024 | 54.99K | $18.07M | 减持 |
| Q1 2025 | 54.49K | $13.27M | 减持 |
| Q2 2025 | 54.10K | $13.05M | 减持 |
| Q3 2025 | 54.13K | $15.18M | 持有 |
| Q4 2025 | 53.97K | $16.35M | 持有 |
| Q1 2026 | 69.01K | $19.24M | 增持 |
| Q2 2026 | 94.43K | $27.73M | 增持 |
| Q3 2026 | 95.47K | $36.06M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BIO 与 13F 数据
BIO(BIO RAD LABS INC)属于工业行业。我们追踪的基金中还有 25 只申报持有 BIO,申报仓位最大的包括:First Eagle 投资管理 (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BIO 的基金
- First Eagle 投资管理 2.46M 股 · $927.50M · Q3 2026
- ARIEL INVESTMENTS, LLC 789.34K 股 · $298.14M · Q3 2026
- EARNEST PARTNERS LLC 567.82K 股 · $214.47M · Q3 2026
- First Pacific Advisors, LP 269.08K 股 · $101.63M · Q3 2026
- NOMURA HOLDINGS INC 328.90K 股 · $96.57M · Q2 2026
更多关于 Hosking Partners LLP
常见问题
How long has Hosking Partners LLP held BIO?
Hosking Partners LLP has disclosed BIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Hosking Partners LLP's current position in BIO?
As of Q3 2026, Hosking Partners LLP holds 95.47K shares of BIO (BIO RAD LABS INC), valued at $36.06M, representing 1.28% of its reported portfolio and ranking #28.
Has Hosking Partners LLP been buying or selling BIO?
In the latest 13F filing (Q3 2026), Hosking Partners LLP increased its position in BIO. The position peaked in Q3 2026 at 95.47K shares.
Which other funds hold BIO?
Other major institutional holders of BIO include First Eagle 投资管理, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.